Bellevue Asset Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-100
Closed -$1K 542
2022
Q1
$1K Sell
100
-21
-17% -$235 ﹤0.01% 534
2021
Q4
$2K Sell
121
-11
-8% -$213 ﹤0.01% 529
2021
Q3
$3K Buy
132
+35
+36% +$900 ﹤0.01% 492
2021
Q2
$3K Sell
97
-11
-10% -$415 ﹤0.01% 490
2021
Q1
$4K Buy
108
+22
+26% +$1.03K ﹤0.01% 485
2020
Q4
$5K Buy
86
+16
+23% +$547 ﹤0.01% 446
2020
Q3
$2K Buy
+70
New +$2.21K ﹤0.01% 585

Other funds holding ONEM

Bellevue Asset Management's ONEM Position: Q2 2022 in Review

Bellevue Asset Management sold out of 1Life Healthcare (ONEM) in Q2 2022, closing a stake of 100 shares — an estimated $1K sold.

Bellevue Asset Management first reported a position in ONEM in Q3 2020 and held it in 7 quarters. The position peaked at $5K in Q4 2020. 187 funds tracked by Wall St. Rank hold ONEM as of Q2 2022.

  • Bellevue Asset Management reported no remaining 1Life Healthcare position as of Q2 2022 after selling out during the quarter.
  • Bellevue Asset Management sold 100 1Life Healthcare shares in Q2 2022, an estimated $1K.
  • Bellevue Asset Management first reported a position in 1Life Healthcare in Q3 2020 and held it in 7 quarters.
  • Bellevue Asset Management's 1Life Healthcare position peaked at $5K in Q4 2020.
  • 187 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2022.

Based on Bellevue Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.